Industry 4.0 elements for pharmaceutical development and manufacture
Yükleniyor...
Tarih
2021
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Altınbaş Üniversitesi
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
The innovations of the Industry 4.0 revolution in the New World aim at creating a society where we can
solve many problems in every sector and social life. As a condition for Industry 4.0, industrial sectors are heading
towards digitalization and automation. Pharmaceutical Industry takes its share in this sense and tries to keep up
with this pace in the context of Pharma 4.0 which is a hot topic. However, it is a known fact that developing safe and
effective new treatments is a long, difficult, and expensive process, so FDA released the Pharmaceutical cGMPs for
the 21st-century report and in this report; it specified Quality by Design (QbD) and Process Analytical Technologies
(PAT) initiative to bring a solution. The introduction of the new QbD approach, which advocates providing the quality
within the product with design instead of testing, brought an increase in the quality of the products manufactured,
a decrease in costs and accelerated the market launch of the medicines. Moreover, patient safety is brought to the
fore with better quality medicines and the patient accesses the drug in a shorter time.
Açıklama
Anahtar Kelimeler
Industry 4.0, Pharma 4.0, Qbd, PAT, Pharmaceutical Development, Pharmaceutical Manufacture
Kaynak
AURUM Journal of Health Sciences
WoS Q Değeri
Scopus Q Değeri
Cilt
3
Sayı
1
Künye
Aksu, B., Yeğen, G. (2021). Industry 4.0 elements for pharmaceutical development and manufacture. Aurum Journal of Health Sciences, 3(1), 45-50.
